Valturna (aliskiren and valsartan) Tablets
Date of Approval: September 17, 2009
Company: Novartis
Treatment for: Hypertension
Valturna is a combination of aliskiren (a direct renin inhibitor) and valsartan (an angiotensin II receptor blocker) indicated for the treatment of high blood pressure.
